[
  {
    "ts": null,
    "headline": "Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals",
    "summary": "BMS witnessed the largest growth in market capitalisation of 24.6% to $105bn in Q3 2024.",
    "url": "https://finnhub.io/api/news?id=04d246aa47fd6fb3a5fe1fdde75a1e541f9f2354617de9fd6e631bb51d12ef11",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730914012,
      "headline": "Top 20 biopharmas’ market cap rises 2% in Q3 2024 amid flurry of drug approvals",
      "id": 131132928,
      "image": "https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/11/Market-cap-cw-feat-img.png",
      "related": "ABBV",
      "source": "Yahoo",
      "summary": "BMS witnessed the largest growth in market capitalisation of 24.6% to $105bn in Q3 2024.",
      "url": "https://finnhub.io/api/news?id=04d246aa47fd6fb3a5fe1fdde75a1e541f9f2354617de9fd6e631bb51d12ef11"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
    "url": "https://finnhub.io/api/news?id=2e36d1f9b88d5edd7cce3afe7b566f61c652b54f874d24c752e019dcf1076b08",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730910840,
      "headline": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "id": 131136870,
      "image": "",
      "related": "ABBV",
      "source": "MarketWatch",
      "summary": "AbbVie Inc. stock outperforms competitors despite losses on the day",
      "url": "https://finnhub.io/api/news?id=2e36d1f9b88d5edd7cce3afe7b566f61c652b54f874d24c752e019dcf1076b08"
    }
  },
  {
    "ts": null,
    "headline": "SDY: Dividend Growth ETF With High Turnover And Poor Return",
    "summary": "SPDR S&P Dividend ETF tracks high-yield dividend aristocrats, featuring 133 holdings, a 2.31% yield. Read why SDY may not be the best choice for dividend investors.",
    "url": "https://finnhub.io/api/news?id=75f1f72f31eb78f7bc48d15be5ab0165881c6ee39740327c548f8ed012a96478",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1730867784,
      "headline": "SDY: Dividend Growth ETF With High Turnover And Poor Return",
      "id": 131103213,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1426182282/image_1426182282.jpg?io=getty-c-w1536",
      "related": "ABBV",
      "source": "SeekingAlpha",
      "summary": "SPDR S&P Dividend ETF tracks high-yield dividend aristocrats, featuring 133 holdings, a 2.31% yield. Read why SDY may not be the best choice for dividend investors.",
      "url": "https://finnhub.io/api/news?id=75f1f72f31eb78f7bc48d15be5ab0165881c6ee39740327c548f8ed012a96478"
    }
  }
]